New Anti-Trop-2 Antibody: Exploring the Compound's Promise: Recent findings are the potential of Pamlectabart, a unique antibody directed at Trop-2. This receptor: is increased in several cancers, and the immunotherapy’s ability to couple to Trop-2 appears to cause growth-stopping effects. Preclini